NCT00539890

Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus

A Phase 3 Randomized, Open Label, Multi-Center Comparative Study of Technosphere /Insulin Versus Rapid Acting Insulin in Subjects With Type-2 Diabetes Mellitus Receiving Lantus as Basal Insulin

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (planned)
• Sponsor: Mannkind Corporation · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

To compare the efficacy of prandial TI plus basal insulin versus prandial rapid acting, subcutaneous insulin plus basal insulin in subjects with type 2 diabetes who had an HbA1c \>7.0% and \<11.5%.

Conditions

• Diabetes Type 2

Interventions

Type	Name	Description
DRUG	Technosphere Insulin

Timeline

• Start date: 2005-11-01
• Completion: 2006-07-01
• First posted: 2007-10-05
• Last updated: 2009-10-14

Locations

33 sites across 1 country: Russia